Pharmacogenomic Considerations for Customizing Warfarin Therapy in the Orthopedic Patient

Rhee, Sonja
Walsh, Kelly PharmD
Lewis, Daniel PharmD, BCPS
Davis, George PharmD, BCPS
Smith, Kelly M. PharmD, BCPS, FASHP, FCCP; Section Editor

Ms Rhee and Dr Smith are from the University of Kentucky College of Pharmacy, and Drs Walsh, Lewis, and Davis are from UK Healthcare, Lexington, Kentucky.

Ms Rhee and Drs Walsh, Lewis, Davis, and Smith have no relevant financial relationships to disclose.

Correspondence should be addressed to: Kelly M. Smith, PharmD, BCPS, FASHP, FCCP, University of Kentucky College of Pharmacy, 789 S Limestone, 114H, Lexington, KY 40536 ( [email protected]).

Orthopedics 33(11):p 828-831, November 01, 2010. | DOI: 10.3928/01477447-20100924-19